Literature DB >> 2123035

Thrombolytic therapy in acute MI. Weighing the risks and benefits.

K G Ro1, H V Anderson.   

Abstract

The underlying cause of acute myocardial infarction can now be effectively treated with thrombolytic agents, thereby increasing myocardial salvage and reducing mortality. Clinicians should always be aware of the risk-to-benefit ratio in treating patients with thrombolytic agents and treat each patient on an individual basis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2123035     DOI: 10.1080/00325481.1990.11704770

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  1 in total

1.  Availability of thrombolytic therapy in rural Newfoundland and Labrador.

Authors:  S Marshall; M Godwin; R Miller
Journal:  CMAJ       Date:  1995-01-15       Impact factor: 8.262

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.